MRK

Merck & Co Inc

May 21 • 04:00PM ET

115.88

+2.88 2.55 %

Healthcare • Drug Manufacturers - General • USA • Mega • NYSE

Peers: ABBV AZN JNJ NVS PFE NVO SNY BMY LLY GSK

| Held by: VTI VOO IVV SCHD SPY VTV XLV VIG VYM VHT

Scroll to Statements

Index	DJIA, S&P 500	P/E	32.61	EPS (ttm)	3.55	Insider Own	0.18%	Shs Outstand	2.47B	Perf Week	2.18%
Market Cap	286.20B	Forward P/E	12.02	EPS next Y	9.64	Insider Trans	-7.11%	Shs Float	2.47B	Perf Month	2.65%
Enterprise Value	329.60B	PEG	2.02	EPS next Q	2.11	Inst Own	81.10%	Short Float	1.06%	Perf Quarter	-5.22%
Income	8.94B	P/S	4.37	EPS this Y	-42.78%	Inst Trans	0.25%	Short Ratio	2.75	Perf Half Y	20.17%
Sales	65.51B	P/B	6.24	EPS next Y	87.59%	ROA	7.33%	Short Interest	26.21M	Perf YTD	10.09%
Book/sh	18.58	P/C	49.58	EPS next 5Y	5.95%	ROE	18.97%	52W High	125.14 -7.40%	Perf Year	50.53%
Cash/sh	2.34	P/FCF	20.28	EPS past 3/5Y	8.43% 21.23%	ROIC	9.65%	52W Low	75.40 53.69%	Perf 3Y	0.34%
Dividend Est.	3.21 (2.77%)	EV/EBITDA	13.67	Sales past 3/5Y	3.55% 9.34%	Gross Margin	73.44%	Volatility	2.47% 2.24%	Perf 5Y	53.48%
Dividend TTM	3.32 (2.87%)	EV/Sales	5.03	EPS Y/Y TTM	-48.28%	Oper. Margin	27.50%	ATR (14)	2.69	Perf 10Y	120.52%
Dividend Ex-Date	Mar 16, 2026	Quick Ratio	1.06	Sales Y/Y TTM	2.70%	Profit Margin	13.64%	RSI (14)	55.76	Recom	1.73
Dividend Gr. 3/5Y	5.42% 5.75%	Current Ratio	1.30	EPS Q/Q	-185.47%	SMA20	3.21%	Beta	0.21	Target Price	131.83
Payout	45.05%	Debt/Eq	1.07	Sales Q/Q	3.72%	SMA50	0.27%	Rel Volume	0.76	Prev Close	113.00
Employees	75000	LT Debt/Eq	1.02	Earnings	Apr 30 BMO	SMA200	13.51%	Avg Volume	9.53M	Price	115.88
IPO	Jun 15, 1946	Option/Short	Yes / Yes	EPS/Sales Surpr.	13.15% 2.77%	Trades		Volume	7,402,733	Change	2.55%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)